Ambri revenue, loss down
Thursday, 25 August, 2005
Ambri (ASX:ABI) saw a decrease in its revenue for the 2004-05 financial year of 27 per cent to $1 million (from $1.4 million in the previous year) but the company's loss was also down 22 per cent to $9 million.
Total expenses for 2004-05 were $10 million compared with $12.8 million in 2003-04, due to a reduction in headcount and R&D spending. The company halved its workforce from 76 to 32 people over the financial year, reducing employee expenses to $4.6 million.
Ambri had cash assets of $10.9 million at June 30, 2005.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
